Earnings Feed
Start Free
Home/Filings/4/0001225208-13-024798
4//SEC Filing

Covidien plc 4

Accession 0001225208-13-024798

CIK 0001385187operating
View on SEC.govCompany Profile

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:11 PM ET

Size

22.5 KB

Accession

0001225208-13-024798

Insider Transaction Report

Form 4
Period: 2013-12-05
Covidien plcCOV
Sgrignari Michael
Senior Vice President
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-12-05−5,182→ 15,548 total
    Exercise: $52.53Exp: 2022-12-02→ Ordinary Shares (5,182 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2013-12-05$42.39/sh+6,440$272,992→ 34,725 total
  • Exercise/Conversion

    Ordinary Shares

    2013-12-05$52.53/sh+5,182$272,210→ 50,884 total
  • Exercise/Conversion

    Ordinary Shares

    2013-12-05$49.48/sh+678$33,547→ 51,562 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-12-05−678→ 1,357 total
    Exercise: $49.48Exp: 2021-06-30→ Ordinary Shares (678 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-12-05−5,712→ 5,713 total
    Exercise: $39.18Exp: 2020-11-30→ Ordinary Shares (5,712 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2013-12-05$39.18/sh+5,712$223,796→ 40,437 total
  • Exercise/Conversion

    Ordinary Shares

    2013-12-05$43.44/sh+5,265$228,712→ 45,702 total
  • Sale

    Ordinary Shares

    2013-12-05$67.33/sh−23,277$1,567,199→ 28,285 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-12-05−5,265→ 0 total
    Exercise: $43.44Exp: 2019-11-30→ Ordinary Shares (5,265 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-12-05−6,440→ 12,881 total
    Exercise: $42.39Exp: 2021-11-30→ Ordinary Shares (6,440 underlying)
Footnotes (3)
  • [F1]The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $67.32 to $67.37. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
  • [F2]Adjusted in connection with the spin-off of Covidien's pharmaceuticals business.
  • [F3]Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.

Documents

1 file

Issuer

Covidien plc

CIK 0001385187

→
Entity typeoperating

Related Parties

1
  • filerCIK 0001385187

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:11 PM ET
Size
22.5 KB
View on SEC.gov